← Back to Patent Explorer
EP0092574B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Oligonucleotide therapeutic agent and methods of making same

Assignee: Molecular Biosystems Inc
•
Filing: 1982-10-08
•
Granted: 1992-04-29
•
Expires: 2002-10-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract For use in controlling biologic functions in an organism, a stabilized oligonucleotide, preferably in a phosphotriester form, having a base sequence substantially complementary to a portion of messenger ribonucleic acid coding for a biological component, such as a protein, of the organism. The oligonucleotide has about fourteen bases or more, such as twenty-three bases, and can be a deoxyribo-nucleotide. The oligonucleotide sequence can be derived from the organism's ribonucleic or deoxyribonucleic acid that codes for a vital protein, and can be synthesized in bulk either chemically or by insertion into a plasmid.

Inventors

  • 👤 Richard H. Tullis

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-05 12:41
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C12N15/1131; A; A61; A61K; A61K31/00; A61K31/70; A61K31/7088; A61K31/7135; C07; C07H; C07H21/00; C12N15/1136; C12N2310/00; C12N2310/30; C12N2310/32; C12N2310/321

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 59 words
A method for preparing a therapeutic agent for selectively blocking a translation of mRNA into a targeted protein comprising the manufacturing of a stabilized oligonucleotide of 14 to 23 bases having a base sequence substantial complementary to a portion of the coding region of the mRNA coding for said targeted protein and formulating the same into a therapeutic agent.
Claim 2
Dependent Claim 22 words
A method for preparing a therapeutic agent according to claim 1, characterized in that the oligonucleotide is prepared in a phosphotriester form.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag